| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
CEO and President
1 company
Rieger Jayson serves as a CEO and President at VRCA. Across recent SEC filings that breaks down to 4 buys and 0 sells. Those positions are worth an estimated $1.0M at current prices.
The biggest single holding is VRCA (~$1.0M) as CEO and President. Net of sales, the recent Form 4 record there shows accumulation of 400,209 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 17, 2026 | VRCA Verrica Pharmaceuticals Inc. | CEO and President | Buy | 25,000 | $5.03 | $125,750.00 | +13.7% | - | - | |
| Nov 25, 2025 | VRCA Verrica Pharmaceuticals Inc. | CEO and President | Buy | 94,311 | $4.24 | $400,114.42 | +106.8% | +9.4% | - | |
| Nov 22, 2024 | VRCA Verrica Pharmaceuticals Inc. | CEO and President | Buy | 280,898 | $0.00 | - | +50.9% | -25.4% | -57.7% |